Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
21 Oct 2013 Spanish Researchers Sequence Non-infiltrating Bladder Cancer Exome Genitourinary cancers - Translational research
17 Oct 2013 Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast Cancer Breast cancer
16 Oct 2013 Hitting Angiogenesis in Gastric Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
14 Oct 2013 Adjuvant Chemotherapy with Gemcitabine for Resected Pancreatic Cancer Gastrointestinal cancers
01 Oct 2013 ESMO Press Release: More Research Urged to Compare and Validate Genomic Tests in Oncology - ESMO Press Commentary Personalised medicine
01 Oct 2013 ECC 2013 Press Release: Variations in Death Rates after Surgery for Oesophageal and Gastric Cancers Prompt European Initiative to Improve Patient Outcomes Gastrointestinal cancers
30 Sep 2013 ECC 2013 Press Release: Biological Therapy with Cediranib Improves Survival in Women with Recurrent Ovarian Cancer Gynaecologic malignancies - Anticancer agents & Biologic therapy
30 Sep 2013 ECC 2013 Press Release: New Research shows how Aspirin may act on Blood Platelets to Improve Survival in Colon Cancer Patients Cancer prevention - Gastrointestinal cancers
30 Sep 2013 ESMO Press Release: Only One in Five Female Oncologists Have a Leadership Position Bioethics, legal and economic issues
30 Sep 2013 ECC 2013 Press Release: First Estimate of Amount of Radiotherapy Dose Wasted in Compensating for Tumour Growth between Treatments Breast cancer
30 Sep 2013 ECC 2013 Press Release: Organised Screening for Prostate Cancer using the Prostate-Specific Antigen Test, Does more Harm than Good Cancer prevention - Genitourinary cancers
30 Sep 2013 ECC 2013 Press Release: New Trial Combining Anti-Cancer Drug and Radiotherapy may Result in a new Treatment for the most Aggressive Brain Tumour Central nervous system malignancies - Anticancer agents & Biologic therapy
29 Sep 2013 ESMO Press Release: The landscape of medical oncology in Europe by 2020 - ESMO Commentary Bioethics, legal and economic issues
29 Sep 2013 ESMO Press Release: New approaches to testing cancer drugs needed - ESMO Commentary Personalised medicine
29 Sep 2013 ESMO @ ECC 2013: A Phase III Study of Tivantinib Plus Erlotinib Did Not Meet a Primary Endpoint in Patients with Locally-advanced or Metastatic, Non-squamous NSCLC Lung and other thoracic tumours - Anticancer agents & Biologic therapy